azacitidine and Precancerous Conditions

azacitidine has been researched along with Precancerous Conditions in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (16.67)	18.7374
1990's	2 (16.67)	18.2507
2000's	4 (33.33)	29.6817
2010's	4 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arai, E; Betsuyaku, T; Kanai, Y; Kohno, T; Sato, T; Soejima, K; Tsuta, K; Watanabe, S	1
Afable, M; Cuthbertson, D; Ganetsky, R; Ganetzky, R; Latham, D; List, AF; Loughran, TP; Maciejewski, JP; Paquette, R; Paulic, K; Saba, HI; Sekeres, MA	1
Jang, YK; Park, SH; Shin, JE	1
Basu, PS; Mazumder-Indra, D; Mitra, S; Mondal, RK; Panda, CK; Roy, A; Roychoudhury, S	1
Brown, J; Felix, DH; Fleming, J; Harrison, PR; MacDonald, DG; McGregor, F; Muntoni, A; Parkinson, EK	1
Bang, YJ; Cho, B; Hwang, KS; Jeong, S; Jeoung, DI; Kang, GH; Kim, HY; Lee, H; Lee, HJ; Lee, YS	1
Benhattar, J; Bosman, FT; Braunschweig, R; Clément, G; Pasquier, N	1
Abraham, JM; Cheng, Y; Greenwald, BD; Hamilton, JP; Ito, T; Jin, Z; Kan, T; Meltzer, SJ; Mori, Y; Paun, BC; Sato, F; Wang, S; Yang, J	1
Fenaux, P; Quesnel, B	1
Cihák, A; Veselý, J	1
Daino, L; Feo, F; Lai, P; Pascale, R; Ruggiu, ME; Satta, G; Seddaiu, MA; Sequenza, MJ; Simile, MM; Vannini, MG	1
Nettesheim, P; Walker, C	1

Reviews

1 review(s) available for azacitidine and Precancerous Conditions

Article	Year
P15INK4b gene methylation and myelodysplastic syndromes. Leukemia & lymphoma, 1999, Volume: 35, Issue:5-6 Topics: Acute Disease; Animals; Antimetabolites, Antineoplastic; Azacitidine; Bone Marrow; Carrier Proteins; Cell Cycle; Cell Cycle Proteins; Cell Differentiation; Cell Transformation, Neoplastic; Chromosomes, Human, Pair 9; Clinical Trials, Phase II as Topic; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinases; Decitabine; Disease Progression; DNA Methylation; Genes, p16; Genes, Tumor Suppressor; Hematopoiesis; Humans; Leukemia, Myeloid; Mice; Myelodysplastic Syndromes; Neoplasm Proteins; Precancerous Conditions; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transforming Growth Factor beta; Tumor Suppressor Proteins	1999

Article

Year

P15INK4b gene methylation and myelodysplastic syndromes.

Leukemia & lymphoma, 1999, Volume: 35, Issue:5-6

Topics: Acute Disease; Animals; Antimetabolites, Antineoplastic; Azacitidine; Bone Marrow; Carrier Proteins; Cell Cycle; Cell Cycle Proteins; Cell Differentiation; Cell Transformation, Neoplastic; Chromosomes, Human, Pair 9; Clinical Trials, Phase II as Topic; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinases; Decitabine; Disease Progression; DNA Methylation; Genes, p16; Genes, Tumor Suppressor; Hematopoiesis; Humans; Leukemia, Myeloid; Mice; Myelodysplastic Syndromes; Neoplasm Proteins; Precancerous Conditions; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transforming Growth Factor beta; Tumor Suppressor Proteins

1999

Trials

1 trial(s) available for azacitidine and Precancerous Conditions

Article	Year
Phase I combination trial of lenalidomide and azacitidine in patients with higher-risk myelodysplastic syndromes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, May-01, Volume: 28, Issue:13 Topics: Aged; Azacitidine; Chromosome Aberrations; DNA Methylation; DNA Modification Methylases; DNA Mutational Analysis; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Karyotyping; Lenalidomide; Male; Middle Aged; Mutation; Myelodysplastic Syndromes; Precancerous Conditions; Risk Assessment; Thalidomide; Time Factors; Treatment Outcome; United States	2010

Article

Year

Phase I combination trial of lenalidomide and azacitidine in patients with higher-risk myelodysplastic syndromes.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, May-01, Volume: 28, Issue:13

Topics: Aged; Azacitidine; Chromosome Aberrations; DNA Methylation; DNA Modification Methylases; DNA Mutational Analysis; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Karyotyping; Lenalidomide; Male; Middle Aged; Mutation; Myelodysplastic Syndromes; Precancerous Conditions; Risk Assessment; Thalidomide; Time Factors; Treatment Outcome; United States

2010

Other Studies

10 other study(ies) available for azacitidine and Precancerous Conditions

Article	Year
DNA methylation profiles at precancerous stages associated with recurrence of lung adenocarcinoma. PloS one, 2013, Volume: 8, Issue:3 Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Azacitidine; DNA Methylation; DNA Probes; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, Neoplasm; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Precancerous Conditions; Proportional Hazards Models; RNA, Messenger	2013
Epigenetic up-regulation of leukemia inhibitory factor (LIF) gene during the progression to breast cancer. Molecules and cells, 2011, Volume: 31, Issue:2 Topics: 5' Flanking Region; Azacitidine; Base Sequence; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chromatin Immunoprecipitation; CpG Islands; Disease Progression; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Histones; Humans; Leukemia Inhibitory Factor; Methyl-CpG-Binding Protein 2; Molecular Sequence Data; Precancerous Conditions; Promoter Regions, Genetic; Protein Binding; RNA Interference; RNA, Messenger; Sp1 Transcription Factor; Tumor Stem Cell Assay; Up-Regulation	2011
Inactivation of SLIT2-ROBO1/2 pathway in premalignant lesions of uterine cervix: clinical and prognostic significances. PloS one, 2012, Volume: 7, Issue:6 Topics: Azacitidine; Cell Line, Tumor; Decitabine; DNA Methylation; Female; Gene Silencing; Humans; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Nerve Tissue Proteins; Precancerous Conditions; Prognosis; Promoter Regions, Genetic; Receptors, Immunologic; Roundabout Proteins; Uterine Cervical Neoplasms	2012
Molecular changes associated with oral dysplasia progression and acquisition of immortality: potential for its reversal by 5-azacytidine. Cancer research, 2002, Aug-15, Volume: 62, Issue:16 Topics: Antimetabolites, Antineoplastic; Azacitidine; Cell Cycle Proteins; Cell Transformation, Neoplastic; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Disease Progression; DNA-Binding Proteins; ErbB Receptors; Humans; Mouth Mucosa; Mouth Neoplasms; Polo-Like Kinase 1; Precancerous Conditions; Protein Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Receptors, Retinoic Acid; RNA, Messenger; Telomerase; Tumor Suppressor Protein p53; Tumor Suppressor Proteins	2002
Promoter hypomethylation of a novel cancer/testis antigen gene CAGE is correlated with its aberrant expression and is seen in premalignant stage of gastric carcinoma. Biochemical and biophysical research communications, 2003, Jul-18, Volume: 307, Issue:1 Topics: Antigens, Nuclear; Antimetabolites, Antineoplastic; Azacitidine; Base Sequence; Biomarkers, Tumor; CpG Islands; DEAD-box RNA Helicases; Decitabine; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Hydroxamic Acids; Methylation; Molecular Sequence Data; Neoplasm Staging; Nuclear Proteins; Oligonucleotide Probes; Precancerous Conditions; Promoter Regions, Genetic; Stomach Neoplasms; Transcription Factors; Tumor Cells, Cultured	2003
Alterations of the Wnt signaling pathway during the neoplastic progression of Barrett's esophagus. Oncogene, 2006, May-18, Volume: 25, Issue:21 Topics: Adenocarcinoma; Azacitidine; Barrett Esophagus; beta Catenin; Cell Division; Cell Line, Tumor; CpG Islands; Decitabine; Disease Progression; DNA Methylation; DNA, Neoplasm; Esophageal Neoplasms; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, APC; Humans; Intercellular Signaling Peptides and Proteins; Membrane Proteins; Mucous Membrane; Neoplasm Proteins; Precancerous Conditions; Promoter Regions, Genetic; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering; Signal Transduction; Transfection; Wnt Proteins; Wnt2 Protein	2006
Reprimo methylation is a potential biomarker of Barrett's-Associated esophageal neoplastic progression. Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Nov-15, Volume: 12, Issue:22 Topics: Adenocarcinoma; Aged; Azacitidine; Barrett Esophagus; Carcinoma, Squamous Cell; Cell Cycle Proteins; Cell Line, Tumor; Decitabine; Disease Progression; DNA Methylation; Esophageal Diseases; Esophageal Neoplasms; Female; Genetic Markers; Glycoproteins; Humans; Male; Middle Aged; Polymerase Chain Reaction; Precancerous Conditions	2006
Incorporation of a potent antileukemic agent, 5-aza-2'-deoxycytidine, into DNA of cells from leukemic mice. Cancer research, 1977, Volume: 37, Issue:10 Topics: Animals; Azacitidine; Deoxycytidine; Epithelium; Female; Leukemia L1210; Leukemia, Experimental; Liver; Lymph Nodes; Mice; Mice, Inbred AKR; Mice, Inbred BALB C; Mice, Inbred DBA; Precancerous Conditions; Thymidine	1977
Reversal by 5-azacytidine of the S-adenosyl-L-methionine-induced inhibition of the development of putative preneoplastic foci in rat liver carcinogenesis. Cancer letters, 1991, Volume: 56, Issue:3 Topics: Adenosine; Animals; Azacitidine; Biomarkers, Tumor; Deoxyadenosines; Diethylnitrosamine; gamma-Glutamyltransferase; Liver; Liver Neoplasms, Experimental; Male; Precancerous Conditions; Rats; Rats, Inbred Strains; S-Adenosylhomocysteine; S-Adenosylmethionine; Thionucleosides	1991
In vitro neoplastic progression of rat tracheal epithelial cells transformed by diverse carcinogens. Cancer research, 1989, Aug-15, Volume: 49, Issue:16 Topics: Animals; Azacitidine; Carcinogens; Cell Transformation, Neoplastic; Epithelium; Methylnitronitrosoguanidine; Precancerous Conditions; Rats; Trachea; Tracheal Neoplasms	1989